Online citations, reference lists, and bibliographies.
← Back to Search

Cyclodextrin Formulation Of Dorzolamide And Its Distribution In The Eye After Topical Administration.

H. Sigurdsson, E. Stefánsson, E. Gudmundsdóttir, T. Eysteinsson, M. Thorsteinsdóttir, T. Loftsson
Published 2005 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Due to limited aqueous solubility of dorzolamide at physiologic pH, the pH of Trusopt eye drops (cont. 2% dorzolamide) has to be kept at about 5.65, and to increase the topical bioavailability of the drug from Trusopt the contact time of the drug with the eye surface is increased by increasing the viscosity of the eye drops to 100 cps. This low pH and high viscosity can lead to local irritation. In this study, dorzolamide hydrochloride was formulated as 2% and 4% low viscosity solutions (viscosity 3 to 5 cps) containing randomly methylated beta-cyclodextrin at pH 7.45. These formulations were evaluated in rabbits. The animals were sacrificed at various time points after topical administration of the drug and the dorzolamide concentration determined in the different parts of the eye. Trusopt was used as a reference standard. The topical availability of dorzolamide from the cyclodextrin-containing eye drops appeared to be comparable to that from Trusopt and the drug reached retina and optic nerve to give measurable concentrations for at least 8 h after administration of the eye drops.
This paper references
10.1016/S0021-5155(99)00093-3
Effect of topical dorzolamide on tissue circulation in the rabbit optic nerve head.
Y. Tamaki (1999)
10.1016/S1350-9462(99)00006-3
Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors
M. F. Sugrue (2000)
10.1016/0039-6257(93)90141-S
Minimizing systemic absorption of topically administered ophthalmic drugs.
A. Urtti (1993)
10.1034/J.1600-0420.2002.800211.X
Dorzolamide and ocular blood flow in previously untreated glaucoma patients: a controlled double-masked study.
I. Bergstrand (2002)
10.1016/S0039-6257(97)00053-2
Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.
N. Pfeiffer (1997)
10.1007/s004170050268
Effect of topical dorzolamide on optic nerve head blood flow
L. Pillunat (1999)
10.1016/S1350-9462(03)00064-8
The effects of antiglaucoma and systemic medications on ocular blood flow
V. P. Costa (2003)
10.1111/j.1755-3768.1984.tb05803.x
OCULAR DISTRIBUTION OF TOPICALLY APPLIED ADRENALINE IN ALBINO AND PIGMENTED RABBITS
A. Urtti (1984)
10.1016/S1461-5347(98)00087-X
RECENT DEVELOPMENTS IN OPHTHALMIC DRUG DELIVERY
Shulin Ding (1998)
10.1016/S0169-409X(98)00055-6
Cyclodextrins in ophthalmic drug delivery.
Loftssona (1999)
10.1016/0169-409X(95)00010-5
Ocular absorption following topical delivery
K. Jaervinen (1995)
10.1016/J.EXER.2003.11.010
Dorzolamide induces vasodilatation in isolated pre-contracted bovine retinal arteries.
A. Josefsson (2004)
10.1089/JOP.1988.4.335
Application site dependent ocular absorption of timolol.
A. Urtti (1988)
10.1016/0378-5173(84)90132-7
Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response
A. Urtti (1984)
10.1093/AJHP/22.12.662
Relationship of viscosity, contact time and prolongation of action of methylcellulose-containing ophthalmic solutions.
S. M. Blaug (1965)
10.1016/0378-5173(90)90215-P
Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits
A. Urtti (1990)
10.1111/j.1749-6632.1984.tb12389.x
The General Physiology of Reactions Catalyzed by Carbonic Anhydrase and Their Inhibition by Sulfonamides a
T. Maren (1984)
10.1021/JS9802594
Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.
M. Prausnitz (1998)
Optic nerve oxygen tension in pigs and the effect of carbonic anhydrase inhibitors.
E. Stefánsson (1999)
Dorzolamide effect on ocular blood flow.
A. Martínez (1999)
The pharmacokinetics of a new antiglaucoma drug, latanoprost, in the rabbit.
B. Sjöquist (1998)
10.1016/S0378-5173(02)00438-6
Acetazolamide: future perspective in topical glaucoma therapeutics.
I. P. Kaur (2002)
10.1002/DDR.430100407
Carbonic anhydrase: General perspective and advances in glaucoma research
T. Maren (1987)
Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment.
M. Araie (1982)
10.1089/JOP.1996.12.363
The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
M. F. Sugrue (1996)
10.1016/S0039-6257(99)00111-3
Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution: results from two multicenter comfort studies. Brinzolamide Comfort Study Group.
L. Silver (2000)
10.1089/JOP.1995.11.489
Comparison of concentration-time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits.
A. Acheampong (1995)
10.1023/A:1023015201493
Cyclodextrins in Eye Drop Formulations
E. Stefánsson (2002)
10.1097/00061198-199502000-00012
The Development of Topical Carbonic Anhydrase Inhibitors
T. Maren (1995)



This paper is referenced by
10.1016/J.JPHOTOCHEM.2011.07.013
Self-association of a naphthalene-capped-β-cyclodextrin through cooperative strong hydrophobic interactions
M. González-Álvarez (2011)
10.1021/JE060092T
Binary Mutual Diffusion Coefficients of Aqueous Solutions of β-Cyclodextrin at Temperatures from 298.15 to 312.15 K
A. Ribeiro (2006)
10.1615/CRITREVTHERDRUGCARRIERSYST.V28.I2.20
Newer therapeutic vistas for antiglaucoma medicines.
I. P. Kaur (2011)
10.1007/978-1-4614-1144-4_1
Route-Specific Challenges in the Delivery of Poorly Water-Soluble Drugs
S. Bosselmann (2012)
10.3109/02713683.2010.536294
Formulation of Indomethacin Eye Drops via Complexation with Cyclodextrins
Maaly A Halim Mohamed (2011)
10.1016/S1773-2247(07)50001-8
Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug
T. Loftsson (2007)
10.1016/J.JCONREL.2007.06.021
Novel biomineral-binding cyclodextrins for controlled drug delivery in the oral cavity.
X. Liu (2007)
10.1039/B605640G
Polymeric materials for ophthalmic drug delivery: trends and perspectives
E. Barbu (2006)
10.1248/CPB.58.143
Single and multi-layered nanofibers for rapid and controlled drug delivery.
Anahita Fathi-Azarbayjani (2010)
10.1002/9780470926819.CH8
Cyclodextrin‐Enhanced Drug Delivery through Mucous Membranes
P. Jansook (2011)
10.1089/jop.2019.0032
Novel Triamcinolone Acetonide-Loaded Liposomal Topical Formulation Improves Contrast Sensitivity Outcome After Femtosecond Laser-Assisted Cataract Surgery
Alejandro Gonzalez-De la Rosa (2019)
10.1016/j.ejpb.2010.07.005
Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
P. Jansook (2010)
10.1007/s10847-011-0002-y
Effect of tretinoin inclusion in dimethyl-beta-cyclodextrins on release rate from a hydrogel formulation
A. Ascenso (2011)
10.1111/j.1600-0625.2006.00481.x
Cyclodextrin‐induced apoptosis in human keratinocytes is caspase‐8 dependent and accompanied by mitochondrial cytochrome c release
U. Schönfelder (2006)
10.1080/10717544.2018.1461278
Fabrication of a drug delivery system that enhances antifungal drug corneal penetration
Jingguo Li (2018)
10.1016/j.talanta.2014.06.074
Simultaneous determination of dorzolomide and timolol in aqueous humor: a novel salting out liquid-liquid microextraction combined with HPLC.
A. Mohamed (2014)
10.1007/978-3-319-29346-2_12
Cyclodextrins in Ocular Drug Delivery
Sridhar Anand (2016)
10.1007/978-981-13-7248-3_13
Plant Derived Polysaccharides as Pharmaceutical Excipients: An Overview
Rajendra Awasthi (2020)
10.1055/S-2005-921157
Cyclodextrine zur Funktionalisierung von Textilien - In-vitro-Untersuchungen zur Hautverträglichkeit am Zellkulturmodell
U. Schönfelder (2006)
10.1208/s12249-009-9268-4
Nanoemulsion as a Potential Ophthalmic Delivery System for Dorzolamide Hydrochloride
H. Ammar (2009)
10.1016/j.jchromb.2010.01.041
Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
Alessio Zammataro (2010)
10.3390/pharmaceutics10010010
Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
M. Dubald (2018)
10.1080/10717544.2017.1386733
Photosensitive drugs: a review on their photoprotection by liposomes and cyclodextrins
G. Ioele (2017)
10.1080/10837450.2017.1371191
Phase transition of a microemulsion upon addition of cyclodextrin – applications in drug delivery
Sachin S. Thakur (2018)
10.1016/j.ijbiomac.2016.10.035
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate.
Guoxin Tan (2017)
10.1016/j.ijpharm.2012.11.002
Dexamethasone eye drops containing γ-cyclodextrin-based nanogels.
Maria D. Moya-Ortega (2013)
10.1155/2013/562727
Development of Dorzolamide Loaded 6-O-Carboxymethyl Chitosan Nanoparticles for Open Angle Glaucoma
U. Shinde (2013)
10.1016/J.EJPB.2007.08.002
Use of cyclodextrins in topical formulations: practical aspects.
K. Cal (2008)
10.1002/DDR.20294
Effects of (−)‐carveol and HPMC on the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide formulations in normotensive New Zealand rabbits
M. Afouna (2009)
10.1016/j.ijpharm.2019.118662
Chitosan/Hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: in vitro and in vivo evaluation.
J. Franca (2019)
10.1080/02713683.2019.1567793
Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery
U. Shinde (2019)
10.1111/J.1600-0420.2007.00885.X
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar